- Home
- NWTG vs TCRT Comparison
NWTG vs TCRT Comparison
Compare NWTG & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NWTG | TCRT |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.9M |
| IPO Year | 2022 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NWTG | TCRT |
|---|---|---|
| Price | $1.28 | $2.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 24.4K | 7.7K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.09 | 24.66 |
| EPS | ★ N/A | N/A |
| Revenue | $8,135,000.00 | ★ $15,900,000.00 |
| Revenue This Year | $53.21 | N/A |
| Revenue Next Year | $40.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 136.14 | N/A |
| 52 Week Low | $0.70 | $1.67 |
| 52 Week High | $2.07 | $4.57 |
Technical Indicators
Market Signals| Indicator | NWTG | TCRT |
|---|---|---|
| Relative Strength Index (RSI) | 63.99 | 48.95 |
| Support Level | $0.99 | $1.95 |
| Resistance Level | $1.39 | $2.02 |
| Average True Range (ATR) | 0.08 | 0.07 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 80.00 | 92.11 |
Price Performance
Historical ComparisonAbout NWTG Newton Golf Company Inc.
Newton Golf Co Inc is a technology-forward golf company engaged in designing, manufacturing, and selling performance golf equipment, including premium golf shafts and putters, and focuses on developing technology-driven golf products intended to enhance player performance. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.